These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23856652)

  • 21. Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease.
    Kumar S; Romero J; Mehta NK; Fujii A; Kapur S; Baldinger SH; Barbhaiya CR; Koplan BA; John RM; Epstein LM; Michaud GF; Tedrow UB; Stevenson WG
    Heart Rhythm; 2016 Oct; 13(10):1957-63. PubMed ID: 27392945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolated septal substrate for ventricular tachycardia in nonischemic dilated cardiomyopathy: incidence, characterization, and implications.
    Haqqani HM; Tschabrunn CM; Tzou WS; Dixit S; Cooper JM; Riley MP; Lin D; Hutchinson MD; Garcia FC; Bala R; Verdino RJ; Callans DJ; Gerstenfeld EP; Zado ES; Marchlinski FE
    Heart Rhythm; 2011 Aug; 8(8):1169-76. PubMed ID: 21392586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pleomorphic Ventricular Tachycardias in Nonischemic Cardiomyopathy.
    Nazer B; Hsia HH
    Card Electrophysiol Clin; 2016 Mar; 8(1):131-7. PubMed ID: 26920181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia.
    Piers SR; Tao Q; de Riva Silva M; Siebelink HM; Schalij MJ; van der Geest RJ; Zeppenfeld K
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):774-84. PubMed ID: 25051947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy.
    Piers SR; Tao Q; van Huls van Taxis CF; Schalij MJ; van der Geest RJ; Zeppenfeld K
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):875-83. PubMed ID: 24036134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can ventricular tachycardia non-inducibility after ablation predict reduced ventricular tachycardia recurrence and mortality in patients with non-ischemic cardiomyopathy? A meta-analysis of twenty-four observational studies.
    Hu J; Zeng S; Zhou Q; Zhu W; Xu Z; Yu J; Hong K
    Int J Cardiol; 2016 Nov; 222():689-695. PubMed ID: 27521538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy: A propensity score-matched analysis of in-hospital outcomes in the United States.
    Briceño DF; Gupta T; Romero J; Kolte D; Khera S; Villablanca PA; Tran A; Mohanty S; Trivedi C; Mohanty P; Gianni C; Kim SG; Garcia M; Fonarow GC; Bhatt DL; Natale A; Di Biase L
    J Cardiovasc Electrophysiol; 2018 May; 29(5):771-779. PubMed ID: 29399923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catheter Ablation for Ventricular Tachycardia in Patients with Nonischemic Cardiomyopathy.
    Thompson N; Frontera A; Takigawa M; Cheniti G; Massoullie G; Cochet H; Denis A; Chaumeil A; Derval N; Hocini M; Haissaguerre M; Jais P; Sacher F
    Card Electrophysiol Clin; 2017 Mar; 9(1):47-54. PubMed ID: 28167085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apical ventricular tachycardia morphology in left ventricular nonischemic cardiomyopathy predicts poor transplant-free survival.
    Frankel DS; Tschabrunn CM; Cooper JM; Dixit S; Gerstenfeld EP; Riley MP; Callans DJ; Marchlinski FE
    Heart Rhythm; 2013 May; 10(5):621-6. PubMed ID: 23276817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis comparing outcomes of catheter ablation for ventricular arrhythmia in ischemic versus nonischemic cardiomyopathy.
    Basu-Ray I; Khanra D; Shah SK; Mukherjee A; Char SV; Jain B; Bunch TJ; Gold M; Adeboye AA; Saeed M
    Pacing Clin Electrophysiol; 2021 Jan; 44(1):54-62. PubMed ID: 33216394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of Inducible Nonsustained Ventricular Tachycardias After Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy.
    Fujii A; Nagashima K; Kumar S; Tanigawa S; Baldinger SH; Michaud GF; John RM; Koplan BA; Tokuda M; Inada K; Tedrow UB; Stevenson WG
    Circ Arrhythm Electrophysiol; 2017 Dec; 10(12):. PubMed ID: 29237608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy.
    Marchlinski FE; Callans DJ; Gottlieb CD; Zado E
    Circulation; 2000 Mar; 101(11):1288-96. PubMed ID: 10725289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome of surgical cryoablation for refractory ventricular tachycardia in patients with non-ischemic cardiomyopathy.
    Liang JJ; Betensky BP; Muser D; Zado ES; Anter E; Desai ND; Callans DJ; Deo R; Frankel DS; Hutchinson MD; Lin D; Riley MP; Schaller RD; Supple GE; Santangeli P; Acker MA; Bavaria JE; Szeto WY; Vallabhajosyula P; Marchlinski FE; Dixit S
    Europace; 2018 Mar; 20(3):e30-e41. PubMed ID: 28402404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VT Recurrence After Ablation: Incomplete Ablation or Disease Progression? A Multicentric European Study.
    Berte B; Sacher F; Venlet J; Andreu D; Mahida S; Aldhoon B; DE Potter T; Sarkozy A; Tavernier R; Andronache M; Deneke T; Kautzner J; Berruezo A; Cochet H; Zeppenfeld K; Jaïs P
    J Cardiovasc Electrophysiol; 2016 Jan; 27(1):80-7. PubMed ID: 26471955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia.
    Komatsu Y; Daly M; Sacher F; Cochet H; Denis A; Derval N; Jesel L; Zellerhoff S; Lim HS; Jadidi A; Nault I; Shah A; Roten L; Pascale P; Scherr D; Aurillac-Lavignolle V; Hocini M; Haïssaguerre M; Jaïs P
    J Am Coll Cardiol; 2014 Apr; 63(14):1416-26. PubMed ID: 24486269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types.
    Oloriz T; Silberbauer J; Maccabelli G; Mizuno H; Baratto F; Kirubakaran S; Vergara P; Bisceglia C; Santagostino G; Marzi A; Sora N; Roque C; Guarracini F; Tsiachris D; Radinovic A; Cireddu M; Sala S; Gulletta S; Paglino G; Mazzone P; Trevisi N; Della Bella P
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):414-23. PubMed ID: 24785410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the arrhythmogenic substrate between men and women with nonischemic cardiomyopathy.
    Kuo L; Shirai Y; Muser D; Liang JJ; Castro SA; Santangeli P; Schaller RD; Supple GE; Lin D; Nazarian S; Dixit S; Callans DJ; Marchlinski FE; Frankel DS
    Heart Rhythm; 2019 Sep; 16(9):1414-1420. PubMed ID: 30928785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia.
    Hsia HH; Callans DJ; Marchlinski FE
    Circulation; 2003 Aug; 108(6):704-10. PubMed ID: 12885746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation.
    Kumar S; Barbhaiya C; Nagashima K; Choi EK; Epstein LM; John RM; Maytin M; Albert CM; Miller AL; Koplan BA; Michaud GF; Tedrow UB; Stevenson WG
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):87-93. PubMed ID: 25527825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving our understanding of epicardial ventricular tachycardia in nonischemic cardiomyopathy.
    Shivkumar K; Tung R
    J Am Coll Cardiol; 2009 Aug; 54(9):809-11. PubMed ID: 19695458
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.